Role of vascular endothelial growth factor in ovarian physiology and pathology

被引:290
作者
Geva, E [1 ]
Jaffe, RB [1 ]
机构
[1] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Ctr Reprod Sci, San Francisco, CA 94143 USA
关键词
folliculogenesis; human ovary; ovarian angiogenesis; OHSS; ovarian neoplasms; ovarian pathology; ovarian physiology; PCOS; VEGF/VPF;
D O I
10.1016/S0015-0282(00)00670-1
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To review the current literature on the role of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in ovarian physiology and pathology. Design: A computerized search was conducted to identify relevant in vitro and in vivo studies published in English. MEDLINE, Current Contents, and the Index Medicus were searched for studies published before January 2000. Result(s): VEGF/VPF is an angiogenic factor and a potent mitogen for vascular endothelium. During reproductive life, VEGF/VPF plays a role in the cyclic growth of ovarian follicles and corpus luteum development and maintenance, mediating ovarian angiogenesis. VEGF/VPF expression and secretion are induced by both FSH and LH/hCG receptor-activated pathways. Conclusion(s): VEGF/VPF expression and production within the ovary are critical for normal reproductive function. Defects in angiogenesis may contribute to a variety of disorders including anovulation and infertility, pregnancy loss, ovarian hyperstimulation syndrome, and ovarian neoplasms. (Fertil Steril(R) 2000;74:429-38. (C) 2000 by American Society for Reproductive Medicine.).
引用
收藏
页码:429 / 438
页数:10
相关论文
共 85 条
[41]   A POSSIBLE MECHANISM FOR INHIBITION OF ANGIOGENESIS BY ANGIOSTATIC STEROIDS - INDUCTION OF CAPILLARY BASEMENT-MEMBRANE DISSOLUTION [J].
INGBER, DE ;
MADRI, JA ;
FOLKMAN, J .
ENDOCRINOLOGY, 1986, 119 (04) :1768-1775
[42]   BINDING-SITES FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR ARE LOCALIZED ON ENDOTHELIAL-CELLS IN ADULT-RAT TISSUES [J].
JAKEMAN, LB ;
WINER, J ;
BENNETT, GL ;
ALTAR, CA ;
FERRARA, N .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (01) :244-253
[43]   PATHOPHYSIOLOGY OF REPRODUCTIVE FAILURE AFTER CLOMIPHENE-INDUCED OVULATION [J].
JONES, GS ;
MAFFEZZO.RD ;
STROTT, CA ;
ROSS, GT ;
KAPLAN, G .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1970, 108 (06) :847-&
[44]  
KAMAT BR, 1995, AM J PATHOL, V146, P157
[45]  
KIESER A, 1994, ONCOGENE, V9, P963
[46]   Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: A preliminary report [J].
Krasnow, JS ;
Berga, SL ;
Guzick, DS ;
Zeleznik, AJ ;
Yeo, KT .
FERTILITY AND STERILITY, 1996, 65 (03) :552-555
[47]   Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B, and VEGF-C messenger ribonucleic acid levels in cultured human granulosa-luteal cells [J].
Laitinen, M ;
Ristimaki, A ;
Honkasalo, M ;
Narko, K ;
Paavonen, K ;
Ritvos, O .
ENDOCRINOLOGY, 1997, 138 (11) :4748-4756
[48]   VASCULAR ENDOTHELIAL GROWTH-FACTOR IS A SECRETED ANGIOGENIC MITOGEN [J].
LEUNG, DW ;
CACHIANES, G ;
KUANG, WJ ;
GOEDDEL, DV ;
FERRARA, N .
SCIENCE, 1989, 246 (4935) :1306-1309
[49]   Role of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome [J].
Levin, ER ;
Rosen, GF ;
Cassidenti, DL ;
Yee, B ;
Meldrum, D ;
Wisot, A ;
Pedram, A .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (11) :1978-1985
[50]   HYPOXIA REGULATES VASCULAR ENDOTHELIAL GROWTH-FACTOR GENE-EXPRESSION IN ENDOTHELIAL-CELLS - IDENTIFICATION OF A 5'-ENHANCER [J].
LIU, YX ;
COX, SR ;
MORITA, T ;
KOUREMBANAS, S .
CIRCULATION RESEARCH, 1995, 77 (03) :638-643